Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Quest Diagnostics, Inc shares valued at $153,579 were sold by DELANEY MARK E on May 12 ’25. At $175.72 per share, DELANEY MARK E sold 874 shares. The insider’s holdings dropped to 8,372 shares worth approximately $1.5 million following the completion of this transaction.
Also, DELANEY MARK E sold 874 shares, netting a total of over 153,221 in proceeds. Following the sale of shares at $175.31 each, the insider now holds 7,498 shares.
Before that, DELANEY MARK E had added 874 shares to its account. In a trade valued at $153,221, the Officer bought Quest Diagnostics, Inc shares for $175.31 each.
As published in their initiating research note from Redburn Atlantic on April 02, 2025, Quest Diagnostics, Inc [DGX] has been a Buy and the price target has been revised to $195. Analysts at Citigroup downgraded the stock from ‘”a Buy”‘ to ‘”a Neutral”‘ outlook in a report released in early March. As of January 06, 2025, Leerink Partners has increased its “Market perform” rating to a “an Outperform” for DGX. Earlier on December 17, 2024, Morgan Stanley upgraded its rating. Their new recommendation was “an Overweight” for DGX stock which previously was a “an Equal-weight”.
Analyzing DGX Stock Performance
On last trading session,, Quest Diagnostics, Inc [NYSE: DGX] plunged -0.69% to $178.65. The stock’s lowest price that day was $177.55, but it reached a high of $179.215 in the same session. During the last five days, there has been a drop of approximately -0.17%. Over the course of the year, Quest Diagnostics, Inc shares have jumped approximately 28.56%. Shares of the company reached a 52-week high of $182.38 on 06/16/25 and a 52-week low of $148.70 on 01/16/25.
Support And Resistance Levels for Quest Diagnostics, Inc (DGX)
According to the 24-hour chart, there is a support level at 177.69, which, if violated, would cause prices to drop to 176.74. In the upper region, resistance lies at 179.46. The next price resistance is at 180.28. RSI (Relative Strength Index) is 55.48 on the 14-day chart, showing neutral technical sentiment.
Is Quest Diagnostics, Inc subject to short interest?
Stocks of Quest Diagnostics, Inc saw a sharp steep in short interest on 2025-05-30 dropping by -0.19 million shares to 3.82 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 4.01 million shares. A decline of -4.97% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 3.15 of the overall float, the days-to-cover ratio (short ratio) decline to 3.15.
Which companies own the most shares of Quest Diagnostics, Inc (DGX)?
In terms of Quest Diagnostics, Inc share price expectations, FactSet research, analysts set an average price target of 185.5 in the next 12 months, up nearly 3.11% from the previous closing price of $179.9. Analysts anticipate Quest Diagnostics, Inc stock to reach 195 by 2025, with the lowest price target being 180. In spite of this, 10 analysts ranked Quest Diagnostics, Inc stock as Buy at the end of 2025. On December 10, 2024, Jefferies assigned a price target of “a Buy” to the stock and resumed coverage with a $185.
